The diagnostic value of Ki-67, P53 and P63 in distinguishing partial Hydatidiform mole from hydropic abortion

Wiener Klinische Wochenschrift

Volumn 124, Issue 5-6, 2012, Pages 184-187

  Chen, Yunxin ^a   Shen, Danhua ^a   Gu, Yiqun ^b   Zhong, Pingping ^b   Xie, Junlin ^b   Song, Qiujin ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b Haidian Maternal and Child Health Hospital   (China)

Author keywords

Differential diagnosis; Hydropic abortion; Immunohistochemistry; Ki 67; P53; P63; Partial mole

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53; PROTEIN P57; PROTEIN P63;

ABORTION; ANTIGEN EXPRESSION; ARTICLE; CELL NUCLEUS; CELL POPULATION; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOTROPHOBLAST; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; HYDROPIC ABORTION; IMMUNOCHEMISTRY; MICROSCOPY; PARTIAL HYDATIDIFORM MOLE; PLACENTA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TROPHOBLAST;

ABORTION, SPONTANEOUS; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYDATIDIFORM MOLE; KI-67 ANTIGEN; PREGNANCY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84863726199     PISSN: 00435325     EISSN: 16137671     Source Type: Journal    
DOI: 10.1007/s00508-011-0119-4     Document Type: Article

References (9)

1. Berkowitz R, Goldstein DP. Current management of gestational trophoblastic diseases. Gynecol Oncol 2009;112: 654-62.
2. Fukunaga M, Katabuchi H, Nagasaka T, Mikami Y, Minamiguchi S, Lage JM. Interobserver and intraobserver variability in the diagnosis of hydatidiform mole. Am J Surg Pathol 2005;29:942-7. (Pubitemid 40885018)
3. McConnell TG, Murphy KM, Hafez M, Vang R, Ronnett BM. Diagnosis and Subclassification of Hydatidiform Moles Using p57 Immunohistochemistry and Molecular Genotyping: Validation and Prospective Analysis in Routine and Consultation Practice Settings With Development of an Algorithmic Approach. Am J Surg Pathol 2009;33:805-17.
4. Sabattini E, Bisgaard K, Ascani S, et al. The EnVision++system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, Chem- Mate, CSA, LABC, and SABC techniques. J Clin Pathol 1998;51:506-11. (Pubitemid 28375029)
5. Schammel DP, Bocklage T. p53, PCNA, and Ki-67 in hydropic molar and nonmolar placentas: an immunohistochemical study. Int J Gynecol Pathol 1996;15:158-66. (Pubitemid 26113865)
6. Kale A, Söylemez F, Ensari A. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silverstaining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease. Am J Obstet Gynecol 2001;184:567-74. (Pubitemid 32234967)
7. Halperin R, Peller S, Sandbank J, Bukovsky I, Schneider D. Expression of the p53 Gene and Apoptosis in Gestational Trophoblastic Disease. Placenta 2000;21:58-62. (Pubitemid 30099496)
8. Uzunlar AK, Yilmaz F, Bayhan G, Akkuş Z. Expressions of p53, proliferating cell nuclear antigen, and Ki-67 in gestational trophoblastic diseases. Eur J Gynaecol Oncol 2002;23:79-83. (Pubitemid 34178109)
9. Ramalho LN, Maggiori MS, Ribeiro-Silva A, Peres LC. P63 expression in hydropic abortion and gestational trophoblastic diseases. Placenta 2006;27:740-3.